title: Transient executive dysfunction following STNDBS in Parkinson's disease.
authors.affiliation: Faculté de médecine, Département de réadaptation, Université Laval, Centre de recherche-Robert-Giffard, Centre hospitalier affilié universitaire de Québec, Hôpital de l'Enfant-Jésus, Département des sciences neurologiques, Pavillon Ferdinand-Vandry, Québec, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Auclair-Ouellet
authors.forename: S
authors.initials: S
authors.lastname: Chantal
authors.forename: L
authors.initials: L
authors.lastname: Cantin
authors.forename: M
authors.initials: M
authors.lastname: Prud'homme
authors.forename: M
authors.initials: M
authors.lastname: Langlois
authors.forename: J
authors.initials: J
authors.lastname: Macoir
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003072:Cognition Disorders / Q000209:etiology*; D046690:Deep Brain Stimulation / Q000009:adverse effects*; D056344:Executive Function / Q000502:physiology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010300:Parkinson Disease / Q000628:therapy; D020531:Subthalamic Nucleus / Q000502:physiology*; D013997:Time Factors
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa; D002230:Carbidopa